Caring for People With Sight Loss

January 24, 2020


A submitted column on how to properly care for patients suffering from vision loss from the founder and medical director of Focus Clinics in London.

The Clear Vision of Future Ophthalmology Care

December 24, 2019


A decade of fine-tuning proven therapies and embracing advancing clinical technology has put ophthalmology in a rare space.

Katherine Talcott, MD: 5-Year Review of Endogenous Bacterial Endophthalmitis

October 18, 2019


Katherine Talcott, MD, of Cole Eye Institute, discusses results of a 5-year study examining endogenous bacterial endophthalmitis at a tertiary care center from AAO 2019.

Aleksandra Rachitskaya, MD: Novel Imaging and Surgical Techniques

October 16, 2019


Aleksandra Rachitskaya, MD, of Cole Eye Institute, discusses a presentation she led at AAO 2019 on novel imaging and surgical techniques.

Louis Pasquale, MD: Embracing Technology in Medicine

October 15, 2019


Louis Pasquale, MD, professor of medicine at Icahn School of Medicine at Mount Sinai, discusses how technology and artificial intelligence has been embraced by ophthalmology.

Methotrexate Outperforms Mycophenolate Mofetil for Uveitis Patients

September 10, 2019


Analysis of the FAST trial found that methotrexate performed better head-to-head than mycophenolate mofetil as a corticosteroid-sparing therapy.

FAi Insert for Treatment of Non-Infectious Posterior Segment Uveitis

July 31, 2019


Investigators presented 36-month results of a study which found that treatment with a single intravitreal injection of the FAi provided anti-inflammatory treatment for 3 years in patients with non-infectious uveitis affecting the posterior segment of the eye

Ajay Kuriyan, MD: Educating Patients on Stem Cells

July 29, 2019


Ajay Kuriyan, MD, discusses what he warns patients to be aware of when seeking out treatment from stem cell therapies and why he believes other physicians should as well.

Filgotinib Drives 12-Week Benefit for Rheumatoid Arthritis

July 23, 2019


Investigators found positive results when examining the safety and efficacy of filgotinib in the FINCH 2 phase 3 clinical trial.

Brian Toy, MD: Risk Factors for Uveitis

May 10, 2019


Investigators found that female sex, older age, and certain comorbidities were associated with an increased risk of uveitis.